Zomedica Pharmaceuticals Balance Sheet Statement

ZOM C$0.285 0.0 0.0%

05/02/20

Speculative, Mid Cap,

Market Cap £1.82bn

Enterprise Value £1.78bn

Revenue £n/a

Quality

Value

Momentum

StockRank™

To unlock Zomedica Pharmaceuticals's balance sheet statement please upgrade your membership.

	2016	2016	2017	2018	2019	2020
Period End:	2016-02-29	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31
Period Length:	0	0	0	0	0	0
Currency:	USD	USD	USD	USD	USD	USD

Cash & Equivalents
Cash and Short Term Investments
Accounts Receivable - Trade, Net
Total Receivables, Net
Prepaid Expenses
Total Current Assets

Property/Plant/Equipment, Total - Gross
Accumulated Depreciation, Total
Property/Plant/Equipment, Total - Net
Intangibles, Net
Other Long Term Assets, Total
Total Assets

Payable/Accrued
Notes Payable/Short Term Debt
Current Port. of LT Debt/Capital Leases
Total Current Liabilities

Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities

Redeemable Preferred Stock
Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Total Equity

Total Liabilities & Shareholders’ Equity
Total Common Shares Outstanding
Total Preferred Shares Outstanding

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.